MK 801: A possible neuroprotective agent by poststroke depression?

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 20, Issue 3, 2008, Pages 367-368

  Cam, Ertugrul ^a   Yulug, Burak ^b   Ozan, Erol ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b ULUDAG UNIVERSITY   (Turkey)

^c ATATÜRK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN INFARCTION SIZE; CONTROLLED STUDY; DEPRESSION; LETTER; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

EID: 52649128773     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.3.367     Document Type: Letter

References (6)

1. Rothwell PM: The high cost of nonfunding stroke research: a comparison with heart disease and cancer. Lancet 2001; 357:1612-1616.
2. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischemic stroke: an integrated view. Trends Neurosci 1999; 22:391-397
3. Whyte EM, Mulsant BH: Poststroke depression: epidemiology, pathophysiology and biological treatment. Biol Psychiatry 2002; 52:253-264
4. Zomkowski AD, Hammes L, Lin J, et al: Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 2002; 25:387-391
5. Chaturvedi HK, Bapna JS, Chandra D: Effect of fluvoxamine and N-methyl-D-aspartate receptor antagonists on shock-induced depression in mice. Indian J Physiol Pharmacol 2001; 45:199-207.
6. Koizumi J, Yoshida Y, Nakazawa T, et al: Experimental studies of ischemic brain edema. Part I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986; 8:1-8 (Japanese)